The Work is still in progress in this new DSpace server.
 

Genome composition and genetic characterization of SARS-CoV-2

No Thumbnail Available

Date

2021

Inventor

Consignee

Journal Title

Journal ISSN

Volume Title

Publisher

Type

Articles

item.page.dc.contributor.department

item.page.publisherplace

Alternative Title

Abstract

SARS-CoV-2 is a type of Betacoronaviruses responsible for COVID-19 pandemic disease, with more than 1.745 million fatalities globally as of December-2020. Genetically, it is considered the second largest genome of all RNA viruses with a 5′ cap and 3′ poly-A tail. Phylogenetic analyses of coronaviruses reveal that SARS-CoV-2 is genetically closely related to the Bat-SARS Like-Corona virus (Bat-SL-Cov) with 96% whole-genome identity. SARS-CoV-2 genome consists of 15 ORFs coded into 29 proteins. At the 5′ terminal of the genome, we have ORF1ab and ORF1a, which encode the 1ab and 1a polypeptides that are proteolytically cleaved into 16 different nonstructural proteins (NSPs). The 3′ terminal of the genome represents four structural (spike, envelope, matrix, and nucleocapsid) and nine accessory (3a, 3b, 6, 7a, 7b, 8b, 9a, 9b, and orf10) proteins. As the number of COVID-19 patients increases dramatically worldwide, there is an urgent need to find a quick and sensitive diagnostic tool for controlling the outbreak of SARS-CoV-2 in the community. Today, molecular testing methods utilizing viral genetic material (e.g., PCR) represent the crucial diagnostic tool for the SARS-CoV-2 virus despite its low sensitivity in the early stage of viral infection. This review summarizes the genome composition and genetic characterization of the SARS-CoV-2.

Description

Q1 Journal

Keywords

Coronaviruses, SARS-CoV-2, COVID-19, Genome

International Classification

Citation

Series

DOI

https://doi.org/10.1016/j.sjbs.2020.12.053

Degree

Govdoc

Isbn

Ismn

Issn

1319-562X

Patent Number

Volume

28

Issue

3